Scientist - Vaccine Development - werkgeversreview Scientist bij Merck

1,0
8 mei 2018
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Smart people, exciting and meaningful work, good experience in the pharmaceutical industry, stability (depending on the department), nice facilities (West Point)

Minpunten

Low Compensation for the industry, middle management not properly trained to lead teams, constant restructuring and reorganization, limited pipeline, bureaucratic organization with lots of politics between and within departments, hard to advance and move up, cutthroat and noninclusive culture. There are much better pharma companies who treat their employees better and offer far better opportunities.

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle